Treatment of a vasoproliferative tumour with intravitreal bevacizumab (Avastin).
Kenawy
N
N
Groenwald
C
C
Damato
B
B
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D005260:Female; D006801:Humans; D008875:Middle Aged; D009383:Neoplasms, Vascular Tissue / Q000188:drug therapy*; D019572:Retinal Neoplasms / Q000188:drug therapy*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab